Mantle cell lymphoma (MCL) accounts for approximately 7% of newly diagnosed non-Hodgkin lymphomas and in most instances is characterized by overexpression of cyclin D1 (CCND1) as a result of translocation t(11;14) (q13;q32). The gene discussed is CCND1; the disease is non-Hodgkin lymphoma.